A pilot study of IW-6463, a CNS-penetrant sGC stimulator, in individuals with MELAS
Wellcome Mitochondrial Medicine Meeting (2020)
This poster details the study design of a Phase 2a pilot study of CY6463 (IW-6463) in participants with MELAS.
Wellcome Mitochondrial Medicine Meeting (2020)
This poster details the study design of a Phase 2a pilot study of CY6463 (IW-6463) in participants with MELAS.